Japan Pharmaceutical Cannabis Market was valued at USD 0.2 Billion in 2022 and is projected to reach USD 1.1 Billion by 2030, growing at a CAGR of 22.0% from 2024 to 2030.
The Japan Pharmaceutical Cannabis Market is rapidly evolving as the country takes steps towards legalizing medicinal cannabis. This shift is being driven by growing recognition of cannabis’s therapeutic potential and the need to address various health conditions. As Japan embraces cannabis for medicinal use, it is crucial to understand the types of cannabis products available and the requirements from industries that will shape this market’s future.
Medicinal cannabis in Japan is being introduced under strict regulations. While recreational cannabis remains illegal, the pharmaceutical market is seeing growing support. The main types of pharmaceutical cannabis available are oils, tinctures, capsules, and topicals. These products are primarily intended for patients suffering from conditions such as chronic pain, anxiety, and epilepsy. The demand for cannabis-derived treatments is increasing, and the pharmaceutical cannabis market is expected to grow steadily as more people seek alternative therapies to traditional medications.
The requirement from industries is a critical factor in the development of this market. Pharmaceutical companies, healthcare providers, and manufacturers of cannabis-based products are working together to ensure that the products meet stringent safety and efficacy standards. Regulatory bodies in Japan are setting guidelines for cultivation, production, and distribution, which will help ensure that only safe, high-quality products reach the market.
Additionally, the Japanese pharmaceutical industry is focusing on research and development to explore new ways cannabis can benefit medical treatments. As the market matures, collaboration between Japanese companies and international cannabis producers is likely to expand, bringing more innovation to the market. However, the need for regulatory clarity remains a significant challenge, and the industry will need to navigate evolving laws and consumer demand carefully.
One of the key requirements is ensuring that the cannabis used in pharmaceutical products is cultivated with precision and care. This includes developing high-quality strains that meet specific medical needs, as well as ensuring that cultivation practices align with the regulations set by the Japanese government. Moreover, patient education will be crucial, as many people are still unfamiliar with the medical benefits of cannabis. As awareness grows, demand for pharmaceutical cannabis will likely rise, creating a dynamic market environment.
Get an In-Depth Research Analysis of the Japan Pharmaceutical Cannabis Market Size And Forecast [2025-2032]
Â
Canopy Growth Corporation
GW Pharmaceuticals
plc
Aurora Cannabis
Inc.
Aphria
Inc.
MedReleaf Corporation
Insys Therapeutics
Inc.
CanniMed Therapeutics
Inc.
Cara Therapeutics
Inc.
United Cannabis Corporation
Â
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the Japan Pharmaceutical Cannabis Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the Japan Pharmaceutical Cannabis Market
CBD Oil
THC Oil
Capsules & Tablets
Tinctures
Topicals (Lotions, Creams)
Edibles (Gummies, Chocolates)
Pain Management
Anxiety & Stress Relief
Neurological Disorders (Epilepsy, MS)
Oncology (Cancer-related symptoms)
Gastrointestinal Disorders (IBS, Crohn’s)
Sleep Disorders
Organic Cannabis
Conventional Cannabis
FDA-approved Strains
Genetically Modified Cannabis
Pharmacies
Online Retail
Specialized Clinics
Direct-to-Consumer Sales
Health and Wellness Stores
18-24 years
25-34 years
35-44 years
45-54 years
55 years and above
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
For More Information or Query, Visit @ Japan Pharmaceutical Cannabis Market Research Analysis
1. Introduction of the Japan Pharmaceutical Cannabis Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. Japan Pharmaceutical Cannabis Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. Japan Pharmaceutical Cannabis Market, By Type
6. Japan Pharmaceutical Cannabis Market, By Application
7. Japan Pharmaceutical Cannabis Market, By Geography
Asia-Pacific
China
Japan
Korea
India
Australia
Indonesia
Thailand
Philippines
Malaysia and Vietnam
8. Japan Pharmaceutical Cannabis Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Research and Consulting firm servicing over 5000+ clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/